Piperacillin, Tazobactam
- Product NDC
- 25021-177
- 11-digit product format
- 250210177
- Labeler code
- 25021
- Product ID
- 25021-177_9481aa66-ddcc-4946-b867-632aaa927e12
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Piperacillin Sodium, Tazobactam Sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA208674
- Marketing category
- ANDA
- Marketing start
- 2021-10-15
- Marketing end
- 0000-00-00
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 4 g/20mL; g/20mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-177-50 | 25021017750 | 10 VIAL in 1 CARTON (25021-177-50) > 20 mL in 1 VIAL | 10 vial | 2021-08-15 | 0000-00-00 | No | No | Current |